<DOC>
	<DOCNO>NCT00076076</DOCNO>
	<brief_summary>The purpose study confirm dose roflumilast use asthma management compare effect 250 mcg 500 mcg oral roflumilast placebo pulmonary function asthma symptom .</brief_summary>
	<brief_title>The FLASH Study : A Study Roflumilast Versus Placebo Patients With Asthma ( BY217/M2-023 )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Main Diagnosis persistent chronic bronchial asthma Baseline lung function within specify parameter No change asthma treatment last 4 week prior start baseline period Stable clinical state Except asthma , good health Nonsmokers exsmokers Main Poorly control asthma Diagnosis chronic pulmonary disease and/or relevant lung diseases Patients use continuously ( 3 day per week ) &gt; 8 puffs/day rescue medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Roflumilast</keyword>
	<keyword>Asthma</keyword>
</DOC>